Clinical Trials

Showing trials with last updates posted in 2021.

NCT03988842 | TERMINATED | PHASE4
4 participants

Standard-dose Apixaban AFtEr Very Low-dose ThromboLYSis for Acute Intermediate-high Risk Acute Pulmonary Embolism

Study Type:
INTERVENTIONAL
Last Updated:
2021-06-11
Start Date:
2019-07-25
Completion:
2020-04-05
Conditions
  • Pulmonary Embolism With Acute Cor Pulmonale
  • Pulmonary Embolism
  • Pulmonary Embolism With Pulmonary Infarction
  • Pulmonary Embolism Subacute Massive
  • Right Ventricular Dysfunction
  • Right Ventricular Failure
Interventions
  • DRUG
Previous
Sorted by latest updates
Next
Showing 40 trials per page